We are live on ! Find out more
QF

QVT Financial Portfolio holdings

AUM $1.37B
1-Year Est. Return 148.1%
This Fund
S&P 500
This Quarter Est. Return
-4.37%
1 Year Est. Return
+148.1%
3 Year Est. Return
+280.64%
5 Year Est. Return
+413.55%
10 Year Est. Return
+2,213.36%
AUM
$1.63B
AUM Growth
-$150M
Cap. Flow
-$291M
Cap. Flow %
-17.86%
Top 10 Hldgs %
46.19%
Holding
94
New
14
Increased
26
Reduced
7
Closed
10

Sector Composition

Rank Sector Weight
1 Healthcare 14.62%
2 Technology 9.36%
3 Financials 7.84%
4 Communication Services 4.65%
5 Consumer Discretionary 3.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
MRTX
26
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
$12M 0.73%
558,625
+307,488
+122% +$6.88M
XLNX
27
DELISTED
Xilinx Inc
XLNX
$11.2M 0.69%
+236,855
New +$11.1M
Z icon
28
Zillow
Z
$7.04B
$11M 0.68%
465,000
+40,000
+9% +$836K
NVGS icon
29
Navigator Holdings
NVGS
$1.34B
$10.5M 0.64%
650,769
-1,241,193
-66% -$18.1M
VNET
30
VNET Group
VNET
$2.05B
$10.5M 0.64%
525,189
TSM icon
31
PUT
TSMC
TSM
$2.09T
$10.5M 0.64%
400,000
-500,000
-56% -$11.7M
ICPT
32
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
$10.3M 0.63%
80,044
+75,793
+1,783% +$8.95M
NXEO
33
DELISTED
Nexeo Solutions, Inc. Common Stock
NXEO
$10M 0.62%
1,000,000
SCTY
34
DELISTED
SolarCity Corporation
SCTY
$10M 0.61%
406,816
SCTY
35
PUT
DELISTED
SolarCity Corporation
SCTY
$9.98M 0.61%
406,000
ARWR icon
36
Arrowhead Research
ARWR
$12.1B
$9.87M 0.61%
2,047,782
+96,400
+5% +$406K
ZG icon
37
Zillow
ZG
$7.02B
$8.94M 0.55%
350,000
SRPT icon
38
Sarepta Therapeutics
SRPT
$1.66B
$8.78M 0.54%
449,526
+325,676
+263% +$5.69M
BMRN icon
39
BioMarin Pharmaceuticals
BMRN
$11.5B
$8.77M 0.54%
106,289
+79,749
+300% +$6.49M
W icon
40
Wayfair
W
$11.1B
$8.64M 0.53%
200,000
W icon
41
PUT
Wayfair
W
$11.1B
$8.64M 0.53%
200,000
RY icon
42
PUT
Royal Bank of Canada
RY
$291B
$8.63M 0.53%
+150,000
New +$7.77M
BRFS
43
DELISTED
BRF SA
BRFS
$8.63M 0.53%
607,112
KKR icon
44
KKR & Co
KKR
$89.2B
$8.29M 0.51%
+564,149
New +$7.68M
IOVA icon
45
Iovance Biotherapeutics
IOVA
$2.23B
$8.12M 0.5%
1,598,309
+164,609
+11% +$901K
FPRX
46
DELISTED
Five Prime Therapeutics, Inc.
FPRX
$6.92M 0.42%
170,199
-76,649
-31% -$2.63M
TNK icon
47
Teekay Tankers
TNK
$2.63B
$6.68M 0.41%
227,674
HALO icon
48
Halozyme
HALO
$9.72B
$6.58M 0.4%
694,436
+208,160
+43% +$1.96M
ADAP
49
DELISTED
Adaptimmune Therapeutics
ADAP
$6.37M 0.39%
783,645
+118,079
+18% +$966K
AVXS
50
DELISTED
AveXis, Inc. Common Stock
AVXS
$6.22M 0.38%
+242,756
New +$5.31M

Similar funds

QVT Financial's Q1 2016 Portfolio in Review

As of Q1 2016, QVT Financial held 94 positions worth $1.63B, down 8.4% from $1.78B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

QVT Financial withdrew a net $291M in Q1 2016, closing 10 positions and reducing 7 holdings. Its most notable exit was SANDISK CORP, an estimated $29.5M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 15% of assets, up from 13% a quarter earlier, followed by Technology and Financials.

Against the trend, QVT Financial opened a new position in QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS worth $40.1M.

  • QVT Financial's largest Q1 2016 buy was QIHOO 360 TECHNOLOGY CO LTD ADS RPSTG 3 CL A SHS: 531,047 shares worth $40.1M.
  • QVT Financial added most to Goldman Sachs in Q1 2016, an estimated $66.4M increase.
  • QVT Financial's biggest Q1 2016 reduction was Navigator Holdings, cutting an estimated $18.1M.
  • QVT Financial fully exited SANDISK CORP in Q1 2016, selling an estimated $29.5M.
  • QVT Financial's ten largest holdings make up 46% of its $1.63B portfolio in Q1 2016.
  • QVT Financial opened 14 new positions and closed 10 in Q1 2016.
  • QVT Financial's portfolio value fell 8.4% quarter-over-quarter to $1.63B.

Based on QVT Financial's 13F filing for Q1 2016, filed 16 May 2016.